Be Humble and Keep Learning
Join Cohesity’s Mohit Aron as he explains the importance of learning from mistakes while building world-class solutions to simplify data management.
I think data is the new oil. Arguably it’s more valuable than real oil.
When you're trying to do something for the first time that no one has done before, there's always going to be some mistakes. The important thing is that one who doesn't have the courage to make those mistakes will never get anywhere. Oh I think I’ve probably made every mistake in the book. As an engineer I used to think I could do everything myself. That has definitely changed, it’s a lot more now about the team. We are a lot about culture inside the company. And one of the favorite phrases that my employees have was "Be humble and keep learning."
Cohesity was built to solve a problem that we refer to as mass data fragmentation. Enterprise data today is fragmented all over our customer's infrastructure. Our mission is to simplify data management. Getting insights from your data is very very important. The success of the business these days depends on it. A lot of information can be extracted automatically from the data. Right? There's a lot of machine learning and there's going to be intelligent machines doing a lot of the work for us.
I think the role of tomorrow, I think SoftBank also says it is an AI world. You know when the first computers came out, people had the same fear that now computers are going to take away their jobs. But let's agree that I think computers were a partner. They made us do so much more. And I believe that to a large part AI is also going to be like that. Humans can now do things that were earlier not possible.
An entrepreneur and even the executive staff in a company, they need to have their eye on both growth and profitability. When entrepreneurs tend to move too much towards one direction. Maybe they think too much about growth and not enough about a fiscally responsible way to run their business. In my mind, deliberate irresponsible and that's where the criticism comes. I think the way that technology space ought to change is to basically take a longterm view at things. Have a good balance between growth and profitability. I think if more entrepreneurs do that, I think we'll just have less criticism in the technology space.
So SoftBank has a huge name and they're known to be big thinkers. The way Masa thinks, is 50 years ahead. He's thinking “How would the world look like 50 years from today, and what technologies does the world need to make that vision possible?”, and that rhymed very well with our own vision. Today the Cohesity brand is known throughout the world. Anyone in IT, I would be surprised if they don't know our name. Two years back, I would have been surprised if someone did know our name. That's all happened because of this financing. So it's been a great, great partnership.
I hope to be remembered for a person who started with just something very mundane, a simple problem, and then grew it to a vision that has far reaching consequences, 50 years from today or a hundred years from today. We can remain where we are with all the problems we have in the world today, or go to a better world. That's something that I aspire to do through Cohesity. Bring the data on one platform, make AI possible, make big data computations possible, and the world will be a safer place, a better place.
The information contained in the videos posted on this webpage (the “Information”) serves solely informational purposes, and is not and may not be construed as or relied on in any manner, as legal, business, tax, investment, accounting or other advice or as an offer to sell or a solicitation of an offer to buy limited partnership or comparable limited liability equity interests in SoftBank Vision Fund L.P. (together with, as the context may require, any parallel fund, feeder fund, co-investment vehicle or alternative investment vehicle, “SVF I” or the “Vision Fund I”), or SoftBank Vision Fund II-1 L.P. and SoftBank Vision Fund II-2 L.P. (together with, as the context may require, any parallel fund, feeder fund, co-investment vehicle or alternative investment vehicle, “SVF II” or the “Vision Fund II”, and together with the Vision Fund I, the “Funds”), each managed by SB Investment Advisers (UK) Ltd. (the “Manager” or “SBIA”) and its affiliates. The Information is not intended to be relied upon as the basis for any investment decision, and is not, and should not be assumed to be, complete.
None of the Vision Fund I, Vision Fund II, or any successor fund managed by SBIA, SBIA, SoftBank Group Corp. (together with its affiliates, “SoftBank”) or their respective affiliates makes any representation or warranty, express or implied, as to the accuracy or completeness of the Information and nothing contained therein should be relied upon as a promise or representation as to past or future performance of the Vision Fund I, Vision Fund II or any other entity referenced in the Information or future performance of any successor fund managed by SBIA. SBIA, Softbank or any affiliate of the foregoing or any related person shall have no duty or responsibility to provide the visitors to this webpage with any information regarding the business, operations, property, financial and other condition and creditworthiness of any entities, companies or any of their affiliates to the extent they are discussed therein or to update the Information. Visitors to this webpage accept all risks in relying on the Information or any part thereof for any purpose whatsoever.
Statements contained in the Information (including those relating to current and future market conditions and trends in respect thereof) that are not historical facts are based on current expectations, estimates, projections, opinions and/or beliefs of the individuals making the statements. Such statements involve known and unknown risks, uncertainties and other factors, and undue reliance should not be placed thereon. In addition, no representation or warranty is made with respect to the reasonableness of any estimates, forecasts, illustrations, prospects or returns, which should be regarded as illustrative only, or that any profits will be realized. Certain information contained therein constitutes “forward-looking statements” which can be identified by the use of terms such as “may”, “will”, “should”, “expect”, “project”, “estimate”, “intend”, “continue”, “target” or “believe” (or the negatives thereof) or other variations thereon or comparable terminology. Due to various risks and uncertainties, actual events or results or actual performance of any entity referred to therein may differ materially from those reflected or contemplated in such forward-looking statements. As a result, visitors to this webpage should not rely on such forward-looking statements for any reason. Further, any targets stated therein are based on an assumption that economic, market and other conditions will not deteriorate and, in some cases, improve. These projections involve significant elements of subjective judgement. No representation or warranty is made as to future performance or such forward-looking statements.
Emerging Trends of Biotechnology
In this episode of Harvard Business Review’s Exponential View, Deep Nishar talks with Azeem Azhar about the intersection between genomic technologies and artificial intelligence and the emerging biotech trends that he believes will lead to the next trillion-dollar market.